Premaitha vows to battle legal claim

MANCHESTER-based molecular diagnostics company Premaitha has vowed to fight a “robust defence and counterclaim" for alleged infringements of patents by US company Illumina and its subsidiary of Verinata Health.

The patents in question are European Patent (UK) and relate to Premaitha's IONA non-invasive prenatal (NIPT) test for pregnant women.

The IONA test estimates the risk of a fetus having Down’s syndrome or other serious genetic diseases and has a higher detection rate and lower false positive ... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...